Advertisement for orthosearch.org.uk
Results 1 - 2 of 2
Results per page:
Bone & Joint Research
Vol. 10, Issue 8 | Pages 548 - 557
25 Aug 2021
Tao Z Zhou Y Zeng B Yang X Su M

Aims

MicroRNA-183 (miR-183) is known to play important roles in osteoarthritis (OA) pain. The aims of this study were to explore the specific functions of miR-183 in OA pain and to investigate the underlying mechanisms.

Methods

Clinical samples were collected from patients with OA, and a mouse model of OA pain was constructed by surgically induced destabilization of the medial meniscus (DMM). Reverse transcription quantitative polymerase chain reaction was employed to measure the expression of miR-183, transforming growth factor α (TGFα), C-C motif chemokine ligand 2 (CCL2), proinflammatory cytokines (interleukin (IL)-6, IL-1β, and tumour necrosis factor-α (TNF-α)), and pain-related factors (transient receptor potential vanilloid subtype-1 (TRPV1), voltage-gated sodium 1.3, 1.7, and 1.8 (Nav1.3, Nav1.7, and Nav1.8)). Expression of miR-183 in the dorsal root ganglia (DRG) of mice was evaluated by in situ hybridization. TGFα, CCL2, and C-C chemokine receptor type 2 (CCR2) levels were examined by immunoblot analysis and interaction between miR-183 and TGFα, determined by luciferase reporter assay. The extent of pain in mice was measured using a behavioural assay, and OA severity assessed by Safranin O and Fast Green staining. Immunofluorescent staining was conducted to examine the infiltration of macrophages in mouse DRG.


Orthopaedic Proceedings
Vol. 86-B, Issue SUPP_III | Pages 278 - 278
1 Mar 2004
Su‡rez-Su‡rez M Murcia-Maz—n A Acebal-Cortina G Rodr’guez-L—pez L Nu–o-Mateo J
Full Access

Aims: To compare the vastus muscle-splitting approach and the classical medial parapatellar in total knee replacement. Methods: Prospective clinical and radiographic study in 50 cemented cruciate-retaining prostheses (Interax, Stryker-Howmedica-Osteonics): midvastus approach in 25 and parapatellar medial in 25. Results: There were no differences (p> 0.05) in postoperative femoro-tibial or patelar tilt angles, duration of surgery, drainage bleeding, Hemoglobine and Hematocrite at postoperative day 3, units of blood transfused, complications, hospital stay, range of motion, and score of the American Knee Society at 1, 6, 12 or 24 months. However, the midvastus approach showed less intraoperative lateral retinacular releases, more patients were able to get independent terminal knee extension at postoperative day 5, and the range of motion at discharge was higher (p< 0.05). Conclusions: The midvastus splitting approach can reduce the need to perform lateral retinacular releases, with advantages in the early postoperative range of motion and knee extension ability.